Span 80

Suppliers

Names

[ CAS No. ]:
1338-43-8

[ Name ]:
Span 80

[Synonym ]:
Sorbitane monooleate,sorbitan oleate
Sorbitan Monooleate
armotanmo
EINECS 215-665-4
sorgen40
o250
Oleic acid compound with (2R,3R,4S)-2-((R)-1,2-dihydroxyethyl)tetrahydrofuran-3,4-diol
glycomulo
montan80
(R)-1-((2S,3R,4S)-3,4-Dihydroxytetrahydrofuran-2-yl)-2-hydroxyethyl oleate
ml33f
ml55f
mo33f
(Sorbitan Monooleate)
MFCD00080948
ionets80

Chemical & Physical Properties

[ Density]:
1.1±0.1 g/cm3

[ Boiling Point ]:
579.3±50.0 °C at 760 mmHg

[ Melting Point ]:
0.986ºC

[ Molecular Formula ]:
C24H44O6

[ Molecular Weight ]:
428.603

[ Flash Point ]:
186.2±23.6 °C

[ Exact Mass ]:
428.313782

[ PSA ]:
96.22000

[ LogP ]:
7.14

[ Vapour Pressure ]:
0.0±3.6 mmHg at 25°C

[ Index of Refraction ]:
1.506

[ Stability ]:
Stable. Combustible. Incompatible with strong oxidizing agents.

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
WG2932400
CHEMICAL NAME :
Sorbitan, monooleate
CAS REGISTRY NUMBER :
1338-43-8
LAST UPDATED :
199710
DATA ITEMS CITED :
8
MOLECULAR FORMULA :
C24-H44-O6
MOLECULAR WEIGHT :
428.68
WISWESSER LINE NOTATION :
T5OTJ BV1OV8U9 CQ DQ

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
Standard Draize test
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rabbit
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
254 gm/kg/6W-C
TOXIC EFFECTS :
Liver - changes in liver weight Kidney, Ureter, Bladder - changes in bladder weight Blood - pigmented or nucleated red blood cells

MUTATION DATA

TYPE OF TEST :
DNA inhibition
TEST SYSTEM :
Human Lymphocyte
DOSE/DURATION :
100 ppm
REFERENCE :
BBRCA9 Biochemical and Biophysical Research Communications. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 45,630,1971 *** REVIEWS *** TOXICOLOGY REVIEW JACTDZ Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. Volume(issue)/page/year: 4(3),65,1985 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 83475 No. of Facilities: 11289 (estimated) No. of Industries: 95 No. of Occupations: 73 No. of Employees: 71826 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 83475 No. of Facilities: 14163 (estimated) No. of Industries: 127 No. of Occupations: 106 No. of Employees: 200724 (estimated) No. of Female Employees: 58462 (estimated)

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves

[ Hazard Codes ]:
T+

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
1

[ RTECS ]:
WG2932400

[ HS Code ]:
34021300

Customs

[ HS Code ]: 34021300

Articles

Cytokine pathway disruption in a mouse model of schizophrenia induced by Munc18-1a overexpression in the brain.

J. Neuroinflammation 11 , 128, (2014)

An accumulating body of evidence points to the significance of neuroinflammation and immunogenetics in schizophrenia, and an imbalance of cytokines in the central nervous system (CNS) has been suggest...

Maltodextrin fast dissolving films for quercetin nanocrystal delivery. A feasibility study.

Carbohydr. Polym. 121 , 217-23, (2015)

The objective of this study was to evaluate the feasibility to prepare fast dissolving films as quercetin nanocrystal delivery systems, using maltodextrins as film forming material and glycerin as pla...

Anionic nanoparticles based on Span 80 as low-cost, simple and efficient non-viral gene-transfection systems.

Int. J. Pharm. 476(1-2) , 23-30, (2015)

The existing strategies in the design of non-viral vectors for gene therapy are primarily conceived for cationic systems. However, the safety concerns associated with the use of positively charged sys...


More Articles


Related Compounds

  • Span 60
  • span(dbp)2
  • SPAN polymer
  • Span 20
  • Span 40
  • Cdc25A (80-93) (human) trifluoroacetate salt
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 2-(4-Fluorophenyl)-8-nitroimidazo[1,2-a]pyridine
  • 1-Bromo-2-(tert-pentyl)benzene
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • 6-(3-chloropropoxy)-5-methoxy-1H-indole